Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
Read More…
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone801-568-7000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$62.56 million
Profitability
Miscellaneous
Employees323
Next Earnings Date2/12/2020 (Estimated)
OptionableNot Optionable
Dynatronics (NASDAQ:DYNT) Frequently Asked Questions
What is Dynatronics' stock symbol?
Dynatronics trades on the NASDAQ under the ticker symbol "DYNT."
How were Dynatronics' earnings last quarter?
Dynatronics Co. (NASDAQ:DYNT) posted its quarterly earnings data on Tuesday, November, 12th. The medical equipment provider reported ($0.01) earnings per share for the quarter, hitting the consensus estimate of ($0.01). The medical equipment provider had revenue of $16.39 million for the quarter, compared to analysts' expectations of $16.21 million. Dynatronics had a negative net margin of 1.84% and a negative return on equity of 12.16%. View Dynatronics' Earnings History.
When is Dynatronics' next earnings date?
What guidance has Dynatronics issued on next quarter's earnings?
Dynatronics updated its FY 2020
Pre-Market earnings guidance on Monday, November, 25th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $$58-62 million, compared to the consensus revenue estimate of $$60.97 million.
What price target have analysts set for DYNT?
3 analysts have issued 12-month price objectives for Dynatronics' shares. Their forecasts range from $3.00 to $4.00. On average, they expect Dynatronics' stock price to reach $3.50 in the next twelve months. This suggests a possible upside of 284.7% from the stock's current price. View Analyst Price Targets for Dynatronics.
What is the consensus analysts' recommendation for Dynatronics?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dynatronics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Dynatronics.
Has Dynatronics been receiving favorable news coverage?
News coverage about DYNT stock has trended somewhat negative this week, according to InfoTrie Sentiment. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Dynatronics earned a media sentiment score of -1.4 on InfoTrie's scale. They also gave news articles about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View News Stories for Dynatronics.
Are investors shorting Dynatronics?
Dynatronics saw a decrease in short interest in January. As of January 15th, there was short interest totalling 38,300 shares, a decrease of 39.9% from the December 31st total of 63,700 shares. Based on an average daily trading volume, of 81,700 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.8% of the shares of the company are sold short. View Dynatronics' Current Options Chain.
Who are some of Dynatronics' key competitors?
Some companies that are related to Dynatronics include Co-Diagnostics (CODX), Neovasc (NVCN), Endologix (ELGX), Interpace Diagnostics Group (IDXG), RA Medical Systems (RMED), Lianluo Smart (LLIT), Biostage (BSTG), DarioHealth (DRIO), Titan Medical (TMDI), Obalon Therapeutics (OBLN), Atossa Genetics (ATOS), Avinger (AVGR), PlusTherapeuticsInc . (PSTV), Hancock Jaffe Laboratories (HJLI) and CELLECT BIOTECH/S (APOP).
What other stocks do shareholders of Dynatronics own?
Who are Dynatronics' key executives?
Dynatronics' management team includes the folowing people:
- Dr. Christopher Richard Von Jako, CEO & Director (Age 49)
- Mr. David A. Wirthlin, CFO & Sec. (Age 58)
- Mr. Terry M. Atkinson CPA, CGMA, Director of Accounting (Age 66)
- Mr. Daryl Connell, Chief Information Officer (Age 47)
- Mr. Skyler Black, Corp. Controller (Age 36)
How do I buy shares of Dynatronics?
Shares of DYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Dynatronics' stock price today?
One share of DYNT stock can currently be purchased for approximately $0.91.
How big of a company is Dynatronics?
Dynatronics has a market capitalization of $8.05 million and generates $62.56 million in revenue each year. The medical equipment provider earns $-920,000.00 in net income (profit) each year or ($0.21) on an earnings per share basis. Dynatronics employs 323 workers across the globe.View Additional Information About Dynatronics.
What is Dynatronics' official website?
How can I contact Dynatronics?
Dynatronics' mailing address is 7030 PARK CENTRE DRIVE, COTTONWOOD HEIGHTS UT, 84121. The medical equipment provider can be reached via phone at 801-568-7000 or via email at [email protected]
MarketBeat Community Rating for Dynatronics (NASDAQ DYNT)
MarketBeat's community ratings are surveys of what our community members think about Dynatronics and other stocks. Vote "Outperform" if you believe DYNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe DYNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
